公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 ROCHE DIAGNÓSTICA BRASIL LTDA取消

1,001 记录

产品持有公司班级有效性
TP2, PROTEÍNA TOTAL GEN 210287410488ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TPCU3, PROTEÍNA TOTAL URINA/LCR GEN.310287410365ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TPUC3(Total Protein Urine/CSF Gen.3) - cobas c10287411433ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TRAPtest10287410984ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TRIGL (Triglycerides) - cobas c10287411412ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TRIGL, Triglicérides10287410536ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TROP T SENSITIVO RAPIDO10287410205ROCHE DIAGNÓSTICA BRASIL LTDAIII10/02/2034
TRSF2 (Tina-quant Transferrin ver.2) - cobas c10287411430ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TT - Thrombin Time10287411340ROCHE DIAGNÓSTICA BRASIL LTDAII现有
TT Thrombin Time10287411136ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Tacrolimus Calset10287411026ROCHE DIAGNÓSTICA BRASIL LTDAIII02/12/2033
Testosterona Calset II10287410848ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Tina-quant Antistreptolysin-O II ASLO210287411805ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Tina-quant Cardiac high sensitivity CRP III (HSCRP)10287410563ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Tina-quant D-Dimer Gen.210287410854ROCHE DIAGNÓSTICA BRASIL LTDAIII01/02/2035
Tina-quant D-Dimer cobas c10287411756ROCHE DIAGNÓSTICA BRASIL LTDAIII18/08/2035
Tina-quant Hemoglobin A1c Gen.310287411293ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Tina-quant Hemoglobin A1cDx Gen.310287411760ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Tina-quant Hemoglobin A1cDx Gen.410287411173ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Tobramicina10287410827ROCHE DIAGNÓSTICA BRASIL LTDAII现有
Total MPA Calibrators10287410954ROCHE DIAGNÓSTICA BRASIL LTDAIII25/08/2035
Total MPA Controls10287410953ROCHE DIAGNÓSTICA BRASIL LTDAIII25/08/2035
Tubo Roche para colheita de sangue total10287411686ROCHE DIAGNÓSTICA BRASIL LTDAI现有
Tumores Musculares (Ventana)10287410872ROCHE DIAGNÓSTICA BRASIL LTDAIII17/05/2035
UA2 (Uric acid ver. 2)- cobas c10287411391ROCHE DIAGNÓSTICA BRASIL LTDAII现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家